Cambridge Sequencing Hub Using Life Tech Instruments | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies said today that it has formed a translational research collaboration with the University of Cambridge that will enable researchers to use the firm’s sequencing technologies through the Eastern Sequence and Informatics Hub at Addenbrooke’s Hospital in Cambridge.

Under the collaboration, European researchers studying cancer, diabetes, and other disorders will be able to use three SOLiD 3 Plus Systems for next generation targeted resequencing and whole transcriptome analysis studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.